Autifony Therapeutics Limited (“Autifony”) is a clinical stage biotechnology company dedicated to developing new medicines to treat rare genetic CNS disorders by deploying its pioneering ion channel drug discovery platform.
View Top Employees from Autifony TherapeuticsWebsite | http://www.autifony.com |
Revenue | $8 million |
Funding | $17.6 million |
Employees | 35 (25 on RocketReach) |
Founded | 2011 |
Address | 90 High Holborn, London, Greater London WC1V 6XX, GB |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Drug Discovery, Retail, Science and Engineering, Medical Device, Health Care, Therapeutics |
Web Rank | 9 Million |
Keywords | Autifony Therapeutics, Autifony Therapeutics Ltd, Boehringer Ingelheim Hearing Programme |
Competitors | Acousia Therapeutics GmbH, Audion Therapeutics BV, OticPharma, Inc., Otonomy, Inc, Sound Pharmaceuticals, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular Autifony Therapeutics employee's phone or email?
The Autifony Therapeutics annual revenue was $8 million in 2024.
25 people are employed at Autifony Therapeutics.
Autifony Therapeutics is based in London, Greater London.
The NAICS codes for Autifony Therapeutics are [5417, 54, 541, 541714, 54171].
The SIC codes for Autifony Therapeutics are [873, 87].